News

January 3, 2018

Tel Aviv - Alpha Tau Medical is thrilled to announce that it was selected to present its highly precise and effective Alpha DaRT radiotherapy treatment for solid cancer at the Biotech Showcase™ during J.P. Morgan Healthcare Conference in January 2018.

Alpha Tau Medical...

December 27, 2017

Another year has passed, and the Alpha Tau team doesn’t rest!

Over the holidays, Uzi Sofer and Prof. Keisari have made their way to Asia, where various cancer hospitals are interested in research collaborations to study the Alpha DaRT brachytherapy treatment for solid...

November 15, 2017

IRST Italy and Alpha Tau Medical are all set to treat their first cancer patients. Prof. Kelson and Amnon Gat joined the team in Italy to receive the first Alpha DaRT delivery. This is a significant progress towards international expansion. It will enable the availabil...

October 25, 2017

Alpha Tau Medical è lieta di annunciare l’avvio della sua prima sperimentazione clinica in Italia. Lo studio che sarà condotto presso l’IRST, a Meldola, valuterà la fattibilità, la sicurezza e l’efficacia della terapia Alpha DaRT per il trattamento del carcinoma a cell...

October 25, 2017

Die klinische Studie am IRST in Italien wird die Sicherheit, Ausführbarkeit und Wirksamkeit von Alpha DaRT zur Behandlung von spinozellulären Karzinomen (SZK) der Haut untersuchen.

Alpha Tau Medical verkündet freudig ihre erste klinische Studie in Italien. Die Studie am...

October 19, 2017

Alpha Tau Medical is now initiating its Alpha DaRT clinical trial at IRST, Italy. The great team at IRST and Prof. Yona Keisari as well as Amnon Gat are excited about this opportunity to study the efficacy of Alpha DaRT in cancer patients suffering from Squamous Cell C...

September 20, 2017

After an exiting year of significant progress in research and development, Uzi Sofer invited the whole team to his house in Jerusalem. Jewish new year (Rosh HaShana) is a great opportunity to thank the entire Alpha Tau Team, friends and family for their hard work, effo...

July 17, 2017

Following the promising preliminary clinical results, showing the ability of Alpha DaRT to effectively and safely destroy solid tumors, Alpha Tau Medical raises more capital than planned.

Alpha Tau Medical Ltd. has raised 20% more capital than planned for its Alpha DaRT...

May 14, 2017

As part of only 10 finalists, Alpha Tau was chosen to participate at the Startup Competition for the upcoming Biomed Conference in Israel, May 23rd, 2017. In addition, Prof. Keisari was invited to orally present the highly potent and conformal Alpha DaRT Treatment for...

April 30, 2017

Alpha Tau Medical showed great presence at the American Brachytherapy Society Meeting 2017 in Boston.

Within 3 exciting and busy days, Prof. Keisari and Prof. Kelson successfully presented the promising preliminary results of the Alpha DaRT SCC Head & Neck Clinical Tria...

Please reload

Categories
Please reload

Sign up
Featured Posts